Oligosecretary Myeloma: Prevalence and Its Clinical Significance
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 390
- 试验地点
- 1
- 主要终点
- Number of patients with oligosecretary myeloma among multiple myeloma patients
研究概览
简要总结
In this study, the investigators aim to investigate the prevalence and clinical course of oligosecretary myeloma.
详细描述
Oligosecretary myeloma is a subgroup of multiple myeloma (MM) characterized by low levels of serum and urine monoclonal (M) protein below thresholds of measurable disease (a serum M protein ≥ 1g/dL, a urine M protein ≥ 200mg/day). Patients with oligosecretary myeloma do not have established methods for disease monitoring and clinical informations regarding oligosecretary myeloma are still largely unknown.
In this study, we aimed to investigate the prevalence and clinical course of oligosecretary myeloma.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 17 Years 至 90 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •a subgroup of multiple myeloma (MM) characterized by low levels of serum and urine monoclonal (M) protein below thresholds of measurable disease (a serum M protein ≥ 1g/dL, a urine M protein ≥ 200mg/day)
- •available clinical data
排除标准
- •patients without available clinical data
结局指标
主要结局
Number of patients with oligosecretary myeloma among multiple myeloma patients
时间窗: up to 1 year
次要结局
未报告次要终点
研究者
Kihyun Kim
Professor
Samsung Medical Center